304 related articles for article (PubMed ID: 12089446)
1. Tumor regression by targeted gene delivery to the neovasculature.
Hood JD; Bednarski M; Frausto R; Guccione S; Reisfeld RA; Xiang R; Cheresh DA
Science; 2002 Jun; 296(5577):2404-7. PubMed ID: 12089446
[TBL] [Abstract][Full Text] [Related]
2. Cancer research. Nanoparticles cut tumors' supply lines.
Couzin J
Science; 2002 Jun; 296(5577):2314-5. PubMed ID: 12089416
[No Abstract] [Full Text] [Related]
3. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
Li L; Wartchow CA; Danthi SN; Shen Z; Dechene N; Pease J; Choi HS; Doede T; Chu P; Ning S; Lee DY; Bednarski MD; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1215-27. PubMed ID: 15001266
[TBL] [Abstract][Full Text] [Related]
4. Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.
Bouquet C; Lamandé N; Brand M; Gasc JM; Jullienne B; Faure G; Griscelli F; Opolon P; Connault E; Perricaudet M; Corvol P
Mol Ther; 2006 Aug; 14(2):175-82. PubMed ID: 16600689
[TBL] [Abstract][Full Text] [Related]
5. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis.
Hahn W; Ho SH; Jeong JG; Hahn EY; Kim S; Yu SS; Kim S; Kim JM
Gene Ther; 2004 May; 11(9):739-45. PubMed ID: 15103317
[TBL] [Abstract][Full Text] [Related]
6. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
Xiao F; Wei Y; Yang L; Zhao X; Tian L; Ding Z; Yuan S; Lou Y; Liu F; Wen Y; Li J; Deng H; Kang B; Mao Y; Lei S; He Q; Su J; Lu Y; Niu T; Hou J; Huang MJ
Gene Ther; 2002 Sep; 9(18):1207-13. PubMed ID: 12215887
[TBL] [Abstract][Full Text] [Related]
7. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
[TBL] [Abstract][Full Text] [Related]
8. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
9. Vascular-targeted nanoparticles for molecular imaging and therapy.
Guccione S; Li KC; Bednarski MD
Methods Enzymol; 2004; 386():219-36. PubMed ID: 15120254
[No Abstract] [Full Text] [Related]
10. Endothelial cell-based systemic gene therapy of metastatic melanoma.
Ojeifo JO; Lee HR; Rezza P; Su N; Zwiebel JA
Cancer Gene Ther; 2001 Sep; 8(9):636-48. PubMed ID: 11593332
[TBL] [Abstract][Full Text] [Related]
11. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
Brantley DM; Cheng N; Thompson EJ; Lin Q; Brekken RA; Thorpe PE; Muraoka RS; Cerretti DP; Pozzi A; Jackson D; Lin C; Chen J
Oncogene; 2002 Oct; 21(46):7011-26. PubMed ID: 12370823
[TBL] [Abstract][Full Text] [Related]
12. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of mutant Raf kinase to neovessels causes tumor regression.
Hood JD; Cheresh DA
Cold Spring Harb Symp Quant Biol; 2002; 67():285-91. PubMed ID: 12858551
[No Abstract] [Full Text] [Related]
14. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
[TBL] [Abstract][Full Text] [Related]
15. A multiprong approach to cancer gene therapy by coencapsulated cells.
Cirone P; Shen F; Chang PL
Cancer Gene Ther; 2005 Apr; 12(4):369-80. PubMed ID: 15692610
[TBL] [Abstract][Full Text] [Related]
16. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy.
Moffatt S; Wiehle S; Cristiano RJ
Gene Ther; 2006 Nov; 13(21):1512-23. PubMed ID: 16763664
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
19. [Anti-tumor effect through human endostatin gene transfer in mice bearing B16 melanoma].
Zhang B; Zou W; Wu G; Jin D; Xu D; Zheng Z; Wu Z; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):451-4. PubMed ID: 12485496
[TBL] [Abstract][Full Text] [Related]
20. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
Liao Y; Zou YY; Xia WY; Hung MC
Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
